Molecular diagnosis of COVID-19 in Burkina Faso: successful challenge

Simple item page
dc.contributor.authorZOURE, Abdou Azaque
dc.contributor.authorOUEDRAOGO, Henri Gautier
dc.contributor.authorSAGNA, Tani
dc.date.accessioned2023-04-23T13:24:03Z
dc.date.available2023-04-23T13:24:03Z
dc.date.issued2022-02-28
dc.descriptionInt. J. Biol. Chem. Sci. 16(1): 440-463en_US
dc.description.abstractCOVID-19 has worsened the health situation in Burkina Faso. In fact, the country has known a peak of the second wave, which began in November, and ended around January 2021. Biological diagnosis has played a key role in the management of COVID-19. The aim of this review paper is to address the practical aspects that laboratories have faced in order to meet the challenge of SARS-CoV-2 diagnosis in Burkina Faso. According to international requirements, Burkina Faso has used real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) as the “gold standard” for the diagnosis of COVID-19. From March 9, 2020 to July 31, 2021, in Burkina Faso, laboratories involved in COVID-19 diagnosis analyzed 226,189 samples by molecular tests and 2, 352 samples by rapid antigenic tests, whose peak was in January 2021 with 35,984 samples analyzed. The daily average rate of samples analysis was 456.02 tests. The majority of the individuals requesting COVID-19 tests were travelers (62.00%), followed by contact cases (18.42%), suspected cases (7.95%), voluntary screening (7.57%), and 4.06% of other applicants consisting of health care personnel and at-risk patients. In terms of prevention, vaccines are being administered to the general population. However, some efforts must be made to provide automated sample analysis equipment and complete sequencing of SARS-CoV-2 remains among the challenges.en_US
dc.description.sponsorshipACE Impact: Climate Change, Biodiversity and Sustainable Agricultureen_US
dc.identifier.citationDOI : https://dx.doi.org/10.4314/ijbcs.v16i1.37en_US
dc.identifier.issn1991-8631
dc.identifier.issn1997-342X
dc.identifier.uridx.doi.org/10.4314/ijbcs.v16i1.37
dc.identifier.urihttp://hdl.handle.net/123456789/1558
dc.language.isoenen_US
dc.publisherInternational Journal of Biological and Chemical Sciencesen_US
dc.subjectLaboratory capacityen_US
dc.subjectCOVID-19en_US
dc.subjectBurkina Fasoen_US
dc.subjectT. Rebeca COMPAOREen_US
dc.subjectSerge Théophile SOUBEIGAen_US
dc.subjectKadari CISSEen_US
dc.subjectDinanibé KAMBIREen_US
dc.subjectOumarou OUEDRAOGOen_US
dc.subjectSylvie ZIDAen_US
dc.subjectCharlemagne DABIREen_US
dc.subjectDramane ZONGOen_US
dc.subjectBoubacar SAVADOGOen_US
dc.subjectAlbert Théophane YONLIen_US
dc.subjectAlbert Théophane YONLIen_US
dc.subjectJacques SIMPOREen_US
dc.subjectCCBADen_US
dc.subjectcoen_US
dc.subjectUniversité Félix Houphouët-Boignyen_US
dc.titleMolecular diagnosis of COVID-19 in Burkina Faso: successful challengeen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Molecular diagnosis of COVID-19 in Burkina Faso.pdf
Size:
977.01 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Agriculture